FIRST AMENDMENT TO CONVERTIBLE DEBENTUREConvertible Debenture Amendment • May 15th, 2017 • Tauriga Sciences, Inc. • Medicinal chemicals & botanical products
Contract Type FiledMay 15th, 2017 Company IndustryThis First Amendment to the Convertible Debenture (the “First Amendment”) is entered into as of May 11, 2017 by and among Tauriga Sciences, Inc., a Florida corporation (the “Company”) and Group 10 Holdings LLC (“Holder”) or its registered assigns or successor in interest. The Company and Holder each referred to herein as a “Party” or collectively as the “Parties”.
FIRST AMENDMENT TO CONVERTIBLE DEBENTUREConvertible Debenture Amendment • May 15th, 2017 • Tauriga Sciences, Inc. • Medicinal chemicals & botanical products
Contract Type FiledMay 15th, 2017 Company IndustryThis First Amendment to the Convertible Debenture (the “First Amendment”) is entered into as of May 11, 2017 by and among Tauriga Sciences, Inc., a Florida corporation (the “Company”) and Group 10 Holdings LLC (“Holder”) or its registered assigns or successor in interest. The Company and Holder each referred to herein as a “Party” or collectively as the “Parties”.
FIRST AMENDMENT TO CONVERTIBLE DEBENTUREConvertible Debenture Amendment • May 15th, 2017 • Tauriga Sciences, Inc. • Medicinal chemicals & botanical products
Contract Type FiledMay 15th, 2017 Company IndustryThis First Amendment to the Convertible Debenture (the “First Amendment”) is entered into as of May 11, 2017 by and among Tauriga Sciences, Inc., a Florida corporation (the “Company”) and Group 10 Holdings LLC (“Holder”) or its registered assigns or successor in interest. The Company and Holder each referred to herein as a “Party” or collectively as the “Parties”.